Abstract
Introduction
Normal brain development and function depend on the active transport of folates across the blood-brain barrier. The folate receptor-1 (FR 1) protein is localized at the basolateral surface of the choroid plexus, which is characterized by a high binding affinity for circulating 5-methyltetrahydrofolate (5-MTHF).
Patients and Methods
We report on the clinical and metabolic findings among five children with normal neurodevelopmental progress during the first four to six months followed by the acquisition of a neurological condition which includes marked irritability, decelerating head growth, psychomotor retardation, cerebellar ataxia, dyskinesias (choreoathetosis, ballism), pyramidal signs in the lower limbs and occasional seizures. After the age of six years the two oldest patients also manifested a central visual disorder. Known disorders have been ruled out by extensive investigations. Cerebrospinal fluid (CSF) analysis included determination of biogenic monoamines, pterins and 5-MTHF.
Results
Despite normal folate levels in serum and red blood cells with normal homocysteine, analysis of CSF revealed a decline towards very low values for 5-methyltetrahydrofolate (5-MTHF), which suggested disturbed transport of folates across the blood-brain barrier. Genetic analysis of the FR 1 gene revealed normal coding sequences. Oral treatment with doses of the stable compound folinic acid (0.5 - 1 mg/kg/day Leucovorin®) resulted in clinical amelioration and normalization of 5-MTHF values in CSF.
Conclusion
Our findings identified a new condition manifesting after the age of 6 months which was accompanied by low 5-MTHF in cerebrospinal fluid and responded to oral supplements with folinic acid. However, the cause of disturbed folate transfer across the blood-brain barrier remains unknown.
Key words
Folate - Blood-Brain Barrier - Folate Receptor
References
1
Adams R D, Kubik C S.
Subacute degeneration of the brain in pernicious anemia.
N Engl J Med.
1944;
231
1-9
2
Anderson R G, Kamen B A, Rothberg K G, Lacey S W.
Potocytosis: sequestration and transport of small molecules by caveolae.
Science.
1992;
255
410-411
3
Atkinson I, Garrow T, Brenner A, Shane B.
Human cytosolic folylpoly-γ-glutamate synthase.
Methods Enzymol.
1997;
281
134-140
4
Baethmann M, Wendel U, Hoffmann G F, Gohlich-Ratmann G, Kleinlein B, Seiffert P, Blom H, Voit T.
Hydrocephalus internus in two patients with 5, 10-methylenetetrahydrofolate reductase deficiency.
Neuropediatrics.
2000;
31
314-317
5
Beckman D R, Hoganson G, Berlow S, Gilbert E F.
Pathological findings in 5, 10-methylenetetrahydrofolate deficiency.
Birth Defects.
1987;
23
47-64
6
Blau N, Thöny B, Renneberg A, Penzien J M, Hyland K, Hoffmann G.
Variant of dihydropteridine reductase deficiency without hyperphenylalaninemia: Effect of oral phenylalanine loading.
JIMD.
1999;
22
216-220
7 Blau N, Duran M, Blaskovics (eds) M. Physician's Guide to Laboratory Diagnosis of Metabolic Diseases. Chapter 2: Hyland K et al. Disorders of Neurotransmitter Metabolism. London; Chapman and Hall 1996: 79-98
8
Clayton P T, Smith I, Harding B, Hyland K, Leonard J V, Leeming R J.
Subacute combined degeneration of the cord, dementia and Parkinsonism due to an inborn error of folate metabolism.
J Neurol Neurosurg Psychiatr.
1986;
49
920-927
9
Corbeel L, Van den Berghe G, Jaeken J. et al .
Congenital folate malabsorption.
Eur J Pediatr.
1985;
143
284-290
10 Curtius H C, Blau N, Kuster T. Pterins. Hommes FA Techniques in Diagnostic Human Biochemical Genetics. New York; Wiley-Liss 1991: 377-396
11
Czeizel A E, Dudas I.
Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation.
New Eng J Med.
1992;
327
1832-1835
12
De Marco P, Moroni A, Merello E. et al .
Folate pathway gene alterations in patients with neural tube defects.
Am J Med Genet.
2000;
95
216-223
13
Elwood P C, Nachmanoff K, Saikawa Y. et al .
The divergent 5′ termini of the alpha human folate receptor (hFR) mRNAs originate from two tissue-specific promotors and alternative splicing: characterization of the alpha hFR Gene structure.
Biochemistry.
1997;
36
1467-1478
14
Fan J, Vitols K S, Huennekens F M.
Multiple folate transport systems in L 1210 cells.
Adv Enzyme Regul.
1992;
32
3-15
15
Ghosh S K, Syed S K, Jung S, Paik W K, Kim S.
Substrate specificity for myelin basic protein-specific protein methylase I.
Biochim Biophys Acta.
1990;
1039
142-148
16
Gospe S M, Gietzen D W, Summers P J. et al .
Behavioral and neurochemical changes in folate-deficient mice.
Physiol Behav.
1995;
58
935-941
17
Heil S G, Van der Put N MJ, Trijbels F JM. et al .
Molecular genetic analysis of human folate receptors in neural tube defects.
Eur J Hum Gen.
1999;
7
393-396
18
Holm J, Hansen S I, Hoier-Madsen M, Bostad L.
High-affinity folate binding in human choroid plexus.
Biochem J.
1991;
280
267-271
19
Hyland K, Fryburg J S, Wilson W G. et al .
Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test.
Neurology.
1997;
48
1290-1297
20
Ichinose H, Ohye T, Matsuda Y. et al .
Characterization of mouse and human GTP cyclohydrolase I gene mutations in patients with GTP cyclohydrolase I deficiency.
J Biol Chem.
1995;
270
10062-10071
21
Kamen B A, Capdevila A.
Receptor-mediated folate accumulation is regulated by the cellular folate content.
Proc Natl Acad Sci USA.
1986;
83
5983-5987
22
Kane M A, Elwood P C, Portillo R M, Antony A C, Najfeld V, Finley A, Waxman S, Kolhouse J F.
Influence on immunoreactive folate-binding protein of extracellular folate concentration in cultured human cells.
J Clin Invest.
1988;
81
1398-1406
23
Lever E G, Elwes R DC, Williams A, Reynolds E H.
Subacute combined degeneration of the cord due to folate deficiency: response to methyl-folate treatment.
J Neurol Neurosurg Psychiatr.
1986;
49
1203-1207
24
Mineo C, Anderson R GW.
Potocytosis. Robert Feulgen lecture.
Histochem Cell Biol.
2001;
116
109-118
25
Piedrahita J A, Oetama B, Bennett G D, van Waes J. et al .
Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development.
Nature genetics.
1999;
23
228-232
26
Prasad P D, Ramamoorthy S, Moe A J. et al .
Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells.
Biochim Biophys Acta Molecular Cell Res.
1994;
1223
71-75
27
Ramaekers Th V, Senderek J, Häusler M. et al .
A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophane and carbidopa.
Mol Genet Metab.
2001;
73
179-187
28 Rosenblatt D. Inherited disorders of folate transport and metabolism. Scriver CR, Beaudet AL, Sly WS, Valle D The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York, NY; McGraw-Hill 1995: 3111-3128
29
Rothberg K G, Ying Y, Kolhouse J F. et al .
The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytotic pathway.
J Cell Biology.
1990;
110
637-649
30
Said H M, Nguyen T T, Dyer D L. et al .
Intestinal folate transport: identification of a cDNA involved in folate transport and the functional expression and distribution of its mRNA.
Biochim Biophys Acta Biomembranes.
1996;
1281
164-172
31 Selhub J. Folate binding proteins. Mechanism for placental and intestinal uptake. Allen L, King J, Lönnerdal B Nutrient Relation During Pregnancy, Lactation and Infant Growth. New York; Plenum Press 1994: 141-149
32
Shen F, Ross J F, Wang X. et al .
Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells - cDNA cloning, expression, immunoreactivity and tissue specificity.
Biochemistry.
1994;
33
1209-1215
33
Spector R, Lorenzo A.
Folate transport in the central nervous system.
Am J Physiol.
1975;
229
777-782
34
Spector R.
Micronutrient homeostasis in mammalian brain and cerebrospinal fluid.
J Neurochem.
1989;
53
1667-1674
35
Surtees R.
Biochemical pathogenesis of subacute combined degeneration of the spinal cord and brain.
JIMD.
1993;
16
762-770
36
Surtees R, Heales S, Bowron A.
Association of cerebrospinal fluid deficiency of 5-methyltetrahydrofolate, but not S-adenosylmethionine, with reduced concentrations of the acid metabolites of 5-hydroxytryptamine and dopamine.
Clin Sci (Colch).
1994;
86
697-702
37
Urbach J, Abrahamor A, Grossowicz N.
Congenital isolated folic acid malabsorption.
Arch Dis Child.
1987;
62
78-80
38
Wang T TY, Chandler C J, Halsted C H.
Intracellular pteroylpolyglutamate hydrolase from human jejunal mucosa: isolation and characterization.
J Biol Chem.
1986;
261
13551-13555
39
Wang Y, Zhao R, Russell R G, Goldman I D.
Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis.
Biochim Biophys Acta.
2001;
1513
49-54
40
Weitman S D, Lark R H, Coney L R, Fort D W, Frasca V, Zurawski V R, Kamen B A.
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Cancer Res.
1992;
52
3396-3401
41
Weitman S D, Weinberg A G, Coney L R. et al .
Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis.
Cancer Res.
1992;
52
6708-6711
42
Wevers R A, Hansen S I, Hubar J LMV. et al .
Folate deficiency in cerebrospinal fluid associated with a defect in folate binding protein in the central nervous system.
J Neurol Neurosurg Psychiatr.
1994;
57
223-226
43
Wu D, Pardridge W M.
Blood-brain barrier transport of reduced folic acid.
Pharm Res.
1999;
16
415-419
44
Young S N.
The 1989 Borden Award Lecture. Some effects of dietary components (amino acids, carbohydrate, folic acid) on brain serotonin synthesis, mood, and behavior.
Can J Physiol Pharmacol.
1991;
69
893-903
PD, M. D., Ph. D. V. T. Ramaekers
Division of Paediatric Neurology, Department of Paediatrics, University Hospital Aachen
Pauwelsstraße 30
52074 Aachen
Germany
Email: vramaekers@ukaachen.de